Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Dermoscopy helps accurately diagnose temporal triangular alopecia, avoiding unnecessary treatments.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Mutations in the AR gene cause hair thinning and loss.

New treatments for PCOS are improving fertility and managing symptoms better.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

PRP injections may improve hair thickness and density in female hair loss patients.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.